DocDollars

Heron Therapeutics, Inc.

NC · United States · Reporting entity ID 100000191747

Total reported 2019–2025
$29.2M
#246 of 2,960 reporting companies — 0% of all reported industry payments
$8.85M in general payments across 32,238 records, plus $20.3M in research funding across 921 records.

How it breaks down

General payments $8,849,062
Research funding $20,334,686

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Heron Therapeutics, Inc. reported $29.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #246 of 2,960 reporting companies. 70% of that was research funding and 30% general payments such as consulting, speaking, food and travel. 32,238 general payment records and 921 research records were filed.

Common questions about Heron Therapeutics, Inc.

How much has Heron Therapeutics, Inc. paid US doctors?

Heron Therapeutics, Inc. reported $29,183,748 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $8,849,062 in general payments, $20,334,686 in research funding.

How does Heron Therapeutics, Inc. rank among drug and device companies?

It ranks #246 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Heron Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.